Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin. (2020)
Attributed to:
Development of an opticin-based anti-angiogenic therapeutic for the treatment of ocular disease.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.molpharmaceut.0c00151
PubMed Identifier: 32437164
Publication URI: http://europepmc.org/abstract/MED/32437164
Type: Journal Article/Review
Volume: 17
Parent Publication: Molecular pharmaceutics
Issue: 7
ISSN: 1543-8384